ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. (Q40647881)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2003

Language	Label	Description	Also known as
English	ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002.	scientific article published on July 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

apoptotic process

0 references

Boe Sandahl Sorensen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Niels Tørring

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Frederik Dagnaes-Hansen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ebba Nexø

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Nancy E Hynes

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

142-149

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Specificity within the EGF family/ErbB receptor family signaling network

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Possible autocrine loop of the epidermal growth factor system in patients with benign prostatic hyperplasia treated with finasteride: a placebo-controlled randomized study.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The EGF receptor family as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Tyrosine kinase inhibitors: from rational design to clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

PTEN: life as a tumor suppressor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The role of overexpressed HER2 in transformation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Adsorption of EGF receptor ligands to test tubes--a factor with implications for studies on the potency of these peptides

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10245

21 January 2018

Identifiers

10.1002/PROS.10245

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746839%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40647881&oldid=1504034327"